Definition: A protein kinase inhibitor used as a therapeutic agent in tumors expressing a mutated form of B-RAF.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review date: Sep 19, 2016.